![]()
MIRA INFORM
REPORT
|
Report Date : |
12.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
SARL CPCM |
|
|
|
|
Registered Office : |
209 Villa Chemin
Des Ruines Alger Place 1611, Bordj El Bahri |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Date of Incorporation : |
14.02.2004 |
|
|
|
|
Legal Form : |
Societe Anonyme Responsabilite Limitee |
|
|
|
|
Line of Business : |
wholesaling and distribution
of pharmaceutical drugs and related facilities |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Algeria |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Bottom of Form
Registered Name: SARL CPCM
Requested Name: SARL
CPCM
Other Names: CHIMIE
PHARMACIE COMMERCE MULTIPLE SARL
Physical Address: 209
Villa Chemin Des Ruines Alger Place 1611, Bordj El Bahri
Postal Address: 209
Villa Chemin Des Ruines Alger Place 1611, Bordj El Bahri
Country: Algeria
Phone: +213-21863002/1492
Fax: +213-21863002/1492
Email: None
Website: None
Financial Index as of December 2010 shows subject firm with a medium
risk of credit. We recommend Credit of USD 50,000 on 90 days.
Legal Form: Societe
Anonyme Responsabilite Limitee.
Date Incorporated: 14-02-2004
Reg. Number: Bordj El Bahri, Algeria
Nominal Capital DZD. 5,000,000
Subscribed Capital DZD. 5,000,000
Subscribed Capital is Subscribed in the following form:
Position Shares
Mr. Hakim Bouzid Director
None Parent company.
None Subsidiary company.
None Affiliated company.
None Shareholder of subject firm.
None Branches of the firm
Registered to operate wholesaling and distribution of pharmaceutical
drugs and related facilities
Imports: Asia
Exports: None
Trademarks: None
Terms of sale: Cash
(40%) and 30 days (60%), invoices.
Main Customers: firms
and organizations
Employees: 20
employees.
Vehicles: Several
motor vehicles.
Territory of
sales: Algeria
Location: Owned
premises, 5.000 square feet,
Auditors: Information not available.
Insurance
Brokers: Information not available.
Currency Reported: Algerian Dinar (DZD.)
Approx. Ex. Rate: 1 US Dollar = 72.10 Algerian Dinar
Fiscal
Year End: December 31, 2010
Inflation: According to
information given by independent sources, the
inflation
at December 31st, 2010 was of 13%.
Financial Information not Submitted
Profit and Loss (expressed in DZD.)
2010
Sales 750,000,000
Bank Name: BNP
Branch: Algiers
Comments: None
Experiences: Good
None
This information was obtained from outside sources other than the subject
company itself and confirmed the above subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.37 |
|
UK Pound |
1 |
Rs.70.84 |
|
Euro |
1 |
Rs.62.96 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.